Gossamer Bio reported last month that its only late-stage candidate failed a Phase 3 study in pulmonary arterial hypertension ...
Eleven point four percent of adults aged 65 to 79 years with stage 1 hypertension would not be eligible under 2025 criteria.
A new analysis of updated blood pressure guidelines suggests that many older adults may no longer need to take medication as ...
A new analysis shows the 2025 hypertension guideline’s risk-based framework spares a small subgroup from immediate treatment.
SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...
High blood pressure and kidney disease are two serious health problems that often occur together. When they appear at the ...
Too much salt may inflame the brain, triggering hormones that push blood pressure higher. Scientists found this pathway could explain why many patients resist current hypertension drugs, pointing ...
An analysis of the 2025 AHA/ACC hypertension guidelines found that under the new guidelines, about 11% of adults ages 65 to 79 with stage I hypertension would no longer qualify for blood pressure ...
A simple, drug-free intervention can lower blood pressure as effectively as medication, with some techniques slashing ...
A newly identified brainstem mechanism linking breathing and blood pressure may help explain certain forms of hypertension and point toward new treatment strategies targeting oxygen-sensing cells in ...
The number doctors use to demarcate hypertension keeps going down, a trend applauded by many experts, who point to studies ...
For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results